3Lequesne M.Indices of severity and disease activity for osteoarthritis[J].Semin Arthritis Rheum,1991,20(2):48-54
4Bellamy N, Buchanan WW, Goldsm CH, et al.Validation study of Womac: a health status instrument for measuring clinically important patient relevant outcomes to an rheumatic drub therapy in patients with osteoarthritis of the hip or knee[J].J Rheum,1988,(15):1833-1840
8Zwerina J,Redlich K,Polzer K,et al. TNF-induced structural joint damage is mediated by IL-1 [J]. Proc Natl Acad Sci USA, 2007,104 : 11742-11747.
9Lundberg C,Asberg I,Ionescu M,et al. Changes in cartilage proteoglycan aggrecan after intra-articular injection of interleukin-1 in rabbits:studies of synovial fluid and articular cartilage[J]. Annals Rheum Dis,1996,55(8):525-534.
10Buvanendran A,Kroin JS,Berger RA,et al. Upregulation of prostaglandin E2 and interleukins in the central nervous system and peripheral tissue during and after surgery in humans[J]. Anesthesiology, 2006, 104 (3) : 403.
6Lequesne M.Indices of severity and disease activity for osteoarthritis[J].Semin Arthritis Rheum,1991,20(2):48-54
7Bellamy N, Buchanan WW, Goldsm CH, et al.Validation study of Womac: a health status instrument for measuring clinically important patient relevant outcomes to an rheumatic drub therapy in patients with osteoarthritis of the hip or knee[J].J Rheum,1988,(15):1833-1840
